NCT04648020 2023-05-31
VOICE
Monopar Therapeutics
Phase 2/3 Terminated
Monopar Therapeutics
US Oncology Research
Vigilant Biosciences, Inc.
Swedish Orphan Biovitrum
National Institutes of Health Clinical Center (CC)
National Center for Complementary and Integrative Health (NCCIH)
RxKinetix